Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

At home adaptive dual target deep brain stimulation in Parkinson's disease with proportional control.

Schmidt, Stephen L; Chowdhury, Afsana H; Mitchell, Kyle T; Peters, Jennifer J; Gao, Qitong; Lee, Hui-Jie; Genty, Katherine; Chow, Shein-Chung; Grill, Warren M; Pajic, Miroslav; Turner, Dennis A.

Brain ; 147(3): 911-922, 2024 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-38128546

2.

The use of real-world data for clinical investigation of effectiveness in drug development.

Wang, Peijin; Chow, Shein-Chung.

J Biopharm Stat ; : 1-24, 2024 Mar 22.

Artículo en Inglés | MEDLINE | ID: mdl-38519266

3.

Analysis of innovative two-stage seamless adaptive design with different endpoints and population shift.

Mai, Weijia; Chow, Shein-Chung.

J Biopharm Stat ; : 1-14, 2024 Mar 21.

Artículo en Inglés | MEDLINE | ID: mdl-38515269

4.

On the use of RWD in support of regulatory submission in drug development.

Chow, Shein-Chung; Wang, Peijin.

J Biopharm Stat ; : 1-28, 2024 Mar 19.

Artículo en Inglés | MEDLINE | ID: mdl-38501166

5.

Utility of real-world evidence in biosimilar development.

Arani, Ramin B; Wang, Jessie; Pang, Dong; Sinha, Samriddhi Buxy; Uttenreuther-Fischer, Martina; Chow, Shein-Chung.

J Biopharm Stat ; : 1-11, 2024 Apr 17.

Artículo en Inglés | MEDLINE | ID: mdl-38630550

6.

Ratios of head circumference to ventricular size vary over time and predict eventual need for CSF diversion in intraventricular hemorrhage of prematurity.

Venkatraman, Vishal; Harward, Stephen C; Bhasin, Srijan; Calderon, Kylie; Atkins, Sage L; Liu, Beiyu; Lee, Hui-Jie; Chow, Shein-Chung; Fuchs, Herbert E; Thompson, Eric M.

Childs Nerv Syst ; 40(3): 673-684, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-37812266

7.

Sample size re-estimation in clinical trials.

Wang, Peijin; Chow, Shein-Chung.

Stat Med ; 40(27): 6133-6149, 2021 11 30.

Artículo en Inglés | MEDLINE | ID: mdl-34433225

8.

Innovative design and analysis for rare disease drug development.

Chow, Shein-Chung; Huang, Zhipeng.

J Biopharm Stat ; 30(3): 537-549, 2020 05 03.

Artículo en Inglés | MEDLINE | ID: mdl-32065047

9.

Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles.

Cheng, Bin; Zhang, Bingzhi; Chow, Shein-Chung.

J Biopharm Stat ; 30(3): 564-573, 2020 05 03.

Artículo en Inglés | MEDLINE | ID: mdl-32065018

10.

Some thoughts on the QR method for analytical similarity evaluation.

Son, Sungtaek; Oh, Minkyung; Choo, Minjoo; Chow, Shein-Chung; Lee, Sang Joon.

J Biopharm Stat ; 30(3): 521-536, 2020 05 03.

Artículo en Inglés | MEDLINE | ID: mdl-32089068

11.

Innovative Thinking on Endpoint Selection in Clinical Trials.

Chow, Shein-Chung; Huang, Zhipeng.

J Biopharm Stat ; 29(5): 941-951, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31454270

12.

Probability monitoring procedures for sample size determination.

Huang, Zhipeng; Chow, Shein-Chung.

J Biopharm Stat ; 29(5): 887-896, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31454274

13.

Demonstrating effectiveness or demonstrating not ineffectiveness - A potential solution for rare disease drug product development?

Chow, Shein-Chung; Huang, Zhipeng.

J Biopharm Stat ; 29(5): 897-907, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31454301

14.

The use of 95% CI or 90% CI for drug product development - a controversial issue?

Chow, Shein-Chung; Zheng, Jiayin.

J Biopharm Stat ; 29(5): 834-844, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31454298

15.

Criteria for dose-finding in two-stage seamless adaptive design.

Zheng, Jiayin; Chow, Shein-Chung.

J Biopharm Stat ; 29(5): 908-919, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31495271

16.

Empower clinical development by harnessing data from diverse sources: methodology, applications and regulatory perspectives.

Deng, Shibing; Chow, Shein-Chung.

J Biopharm Stat ; : 1-2, 2024 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-38562054

17.

Statistical considerations for rare diseases drug development.

Chow, Shein-Chung; Chang, Yu-Wei.

J Biopharm Stat ; 29(5): 874-886, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31454299

18.

Interim analysis of binary outcome data in clinical trials: a comparison of five estimators.

Lu, Qing Shu; Chow, Shein-Chung; Tse, Siu-Keung.

J Biopharm Stat ; 29(2): 400-410, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-30599798

19.

Simultaneous confidence interval methods for analytical similarity assessment.

Zheng, Jiayin; Yin, Donglei; Yuan, Mengdie; Chow, Shein-Chung.

J Biopharm Stat ; 29(5): 920-940, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31454290

20.

Inconsistencies in Colonic Tattooing Practice: Differences in Reported and Actual Practices at a Tertiary Medical Center.

Spaete, Joshua P; Zheng, Jiayin; Chow, Shein-Chung; Burbridge, Rebecca A; Garman, Katherine S.

South Med J ; 112(4): 222-227, 2019 04.

Artículo en Inglés | MEDLINE | ID: mdl-30943541

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

At home adaptive dual target deep brain stimulation in Parkinson's disease with proportional control.

The use of real-world data for clinical investigation of effectiveness in drug development.

Analysis of innovative two-stage seamless adaptive design with different endpoints and population shift.

On the use of RWD in support of regulatory submission in drug development.

Utility of real-world evidence in biosimilar development.

Ratios of head circumference to ventricular size vary over time and predict eventual need for CSF diversion in intraventricular hemorrhage of prematurity.

Sample size re-estimation in clinical trials.

Innovative design and analysis for rare disease drug development.

Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles.

Some thoughts on the QR method for analytical similarity evaluation.

Innovative Thinking on Endpoint Selection in Clinical Trials.

Probability monitoring procedures for sample size determination.

Demonstrating effectiveness or demonstrating not ineffectiveness - A potential solution for rare disease drug product development?

The use of 95% CI or 90% CI for drug product development - a controversial issue?

Criteria for dose-finding in two-stage seamless adaptive design.

Empower clinical development by harnessing data from diverse sources: methodology, applications and regulatory perspectives.

Statistical considerations for rare diseases drug development.

Interim analysis of binary outcome data in clinical trials: a comparison of five estimators.

Simultaneous confidence interval methods for analytical similarity assessment.

Inconsistencies in Colonic Tattooing Practice: Differences in Reported and Actual Practices at a Tertiary Medical Center.